Zobrazeno 1 - 10
of 40
pro vyhledávání: '"James J. Cereghino"'
Autor:
James J. Cereghino
Publikováno v:
The Medical Treatment of Epilepsy ISBN: 9781003066736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::105d62c3907c445e9972525575a2694f
https://doi.org/10.1201/9781003066736-92
https://doi.org/10.1201/9781003066736-92
Autor:
James J. Cereghino
Publikováno v:
Current Treatment Options in Neurology. 9:249-255
Acute repetitive seizures are a predictable component of a patient's seizure disorder, historically distinct from the patient's other epileptic seizures in type, frequency, severity, or duration, and with an onset easily recognized by caregiver and p
Publikováno v:
Neurology. 55:236-242
Objective: To evaluate the efficacy and safety of 500 mg bid and 1500 mg bid levetiracetam as adjunctive therapy for refractory partial seizures in a double-blind, randomized, placebo-controlled, parallel-group, multicenter trial.Methods: The authors
Publikováno v:
Epilepsia. 41:868-874
Summary: Purpose: To evaluate the short-term effect of levetiracetam (LEV; UCB L059) as add-on therapy on health-related quality of life in the treatment of refractory partial-onset seizures. Methods: Patients were enrolled in protocol UCB N132 if th
Autor:
P. K. Crumrine, Joan A. Conry, W. E. Rosenfeld, L. Groves, James J. Cereghino, Wendy G. Mitchell, Robert L. Kriel
Publikováno v:
Epilepsia. 40:1610-1617
Summary: Purpose: To assess safety of diazepam rectal gel (DZPRG) for control of acute seizures in epilepsy patients and to evaluate tolerance with repeated use of DZPRG at intervals of ≤5 days. Methods: Subjects were persons with epilepsy, age 2 y
Autor:
Wendy G. Mitchell, Robert L. Kriel, John M. Pellock, James J. Cereghino, James C. Cloyd, N. Paul Rosman
Publikováno v:
Pediatric Neurology. 20:282-288
The purpose of these investigations was to determine from combined data the response to rectal diazepam (DZP) gel (Diastat [Athena Neurosciences, South San Francisco, CA]) in home treatment of children with episodes of acute repetitive seizures (ARS)
Autor:
W. E. Rosenfeld, Jerome V. Murphy, James J. Cereghino, Robert L. Kriel, Wendy G. Mitchell, Edwin Trevathan
Publikováno v:
Neurology. 51:1274-1282
Objective: To evaluate the effectiveness and safety of a single-dose treatment for acute repetitive seizure (ARS) episodes (e.g., clusters) administered in a nonmedical setting by caregivers. Background: Patients with epilepsy may experience ARS epis
Autor:
Margaret Matula, Susan Collins, George L. Morris, J. Todd Sahlroot, Walter Bell, James J. Cereghino
Publikováno v:
Journal of Epilepsy. 10:62-66
Losigamone (LSG) has shown anticonvulsant efficacy and low neurotoxicity in preclinical testing and has been tolerated in Phase I clinical trials. We report an open-label, add-on tolerability study of six ascending LSG dosage levels from 600 to 2,100
Autor:
James J. Cereghino
Publikováno v:
Epilepsia. 50(3)
The management of many of these cases of chronic convulsive disease is a task of difficulty, requiring the utmost patience and perseverance on the part of both the patient and the physician. The old power of casting them out has gone from the earth,
Autor:
C. B. McCutchen, Michael Privitera, David M. Treiman, Gordon W. Pledger, Adrian Handforth, J. T. Sahlroot, J. H. Wood, James J. Cereghino, M. S. Linde
Publikováno v:
Neurology. 44(8)
Background: Dezinamide (DZM, ADD 94057) is a potential antiepileptic drug that binds to the voltage-sensitive sodium channel and showed preliminary evidence of efficacy and safety in an open-label study.Methods: Our double-blind, placebo-controlled t